Retatrutide (RUO)

Also known as: LY3437943, Triple agonist

Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors.

Research context

Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors. It is a subject of active clinical development but remains unapproved. In laboratory research it is used to model tri-agonist receptor pharmacology and study downstream cAMP signaling in transfected cell lines. Supplied as a research reference only.

Storage & stability

Store lyophilized at -20°C.

Purity & testing standards

Each batch of Retatrutide (RUO) is analyzed by an independent third-party laboratory. Standard release testing includes reverse-phase HPLC at 220 nm (purity target HPLC ≥98%), electrospray mass spectrometry (identity confirmation), and endotoxin screening. Batch numbers on each vial resolve to a downloadable COA on this site.